The primary goal of the Phase 3 randomized clinical trial is to determine if lenzilumab can help hospitalized patients with COVID-19 recover faster
Pharma & Biotech
Total net revenue for CannMart for the three-month period to end August 31 was C$2.3 million, a...
The CEO shares exclusively with Proactive how the company plans to cross the finish line with...
The company offered roughly 17.7 million units, each containing one share and one half a...
Pharma & Biotech
Algernon Pharmaceuticals (CSE: AGN-OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling from Proactive to bring news the company has heard from the external Data and Safety Monitoring Board who has once again unanimously approved the continuation of the Company’s multinational Phase 2b/3...
Health
Redhill BioPharma presents at the Proactive One2One virtual conference
Health
Namaste releases third quarter financial numbers showing year over...
Markets brace as US election looms
Next Tuesday, US voters will head to the polls in what has become one of the most volatile and...
The company is a leader for dried flower vaporizers and a pioneer in cannabis telemedicine and...
The CEO shares exclusively with Proactive how the company plans to cross the finish line with...
The company is the owner of North America’s only permitted cobalt refinery located in Ontario,...
The group’s BlackOak Alpha Growth Fund invests in life settlements targeting an annual rate of...
Online business & e-commerce
Online business & e-commerce
Pharma & Biotech
Financial Services
Leisure, gaming and gambling
Pharma & Biotech
Cannabis
Medical technology & services
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
